I just noticed that Astra Zeneca had a nice little dip lately, making it a good time to pick up some shares. With their promising cancer treatment pip...
Read
More
I just noticed that Astra Zeneca had a nice little dip lately, making it a good time to pick up some shares. With their promising cancer treatment pipeline and a solid 2.2% dividend, it feels like a decent investment for the next few months.
I see a solid opportunity with $AZN as I expect it to rebound to the mid to high $70s by early spring. This movement mirrors last winter's trend, and ...
Read
More
I see a solid opportunity with $AZN as I expect it to rebound to the mid to high $70s by early spring. This movement mirrors last winter's trend, and I'm confident in a strong upward potential in the coming weeks.
Given the growing interest in respiratory treatments and AstraZeneca’s market position amidst ongoing scrutiny, I see potential for a short-term uptic...
Read
More
Given the growing interest in respiratory treatments and AstraZeneca’s market position amidst ongoing scrutiny, I see potential for a short-term uptick in AZN shares. With increased demand for respiratory drugs, this presents a timely opportunity for investment before market adjustments occur.